Antimicrobial Agents Practice Questions

Q: Which of the following antimicrobials needs dose reduction even in mild renal failure?

Ethambutol. **Explanation:** The correct answer is **Ethambutol**. **1. Why Ethambutol is correct:** Ethambutol is primarily excreted unchanged by the kidneys (approx. 80%). It has a narrow therapeutic index regarding ocular toxicity (optic neuritis). In renal impairment, the drug accumulates rapidly, significantly increasing the risk of irreversible vision loss. Current guidelines recommend that even in **mild renal failure** (CrCl < 70-100 ml/min), the dose should be monitored, and if CrCl falls below 30 ml/min, the dosing interval must be increased to 3 times weekly rather than daily. **2. Why the other options are incorrect:** * **Ciprofloxacin:** While it is renally excreted, dose reduction is typically only required in **moderate to severe** renal failure (CrCl < 30-50 ml/min). * **Carbenicillin:** This is an antipseudonal penicillin. While it requires adjustment in renal failure to prevent seizures and bleeding diathesis, it has a wider safety margin than ethambutol in mild cases. * **Cefotaxime:** Most cephalosporins have a high therapeutic index. Cefotaxime requires dose adjustment only when the GFR drops below 20 ml/min (**severe** impairment). **3. NEET-PG High-Yield Pearls:** * **Ethambutol Toxicity:** The most characteristic side effect is **retrobulbar neuritis**, resulting in decreased visual acuity and **red-green color blindness**. It is contraindicated in children too young to undergo visual testing. * **Safe in Renal Failure:** Antibiotics like **Ceftriaxone, Doxycycline, Erythromycin, and Rifampicin** are primarily eliminated via the liver/bile and generally do not require dose adjustment in renal failure. * **Rule of Thumb:** Always prioritize dose adjustment for drugs with narrow therapeutic windows (Aminoglycosides, Vancomycin, Ethambutol, Lithium) in renal patients.

Q: Which anti-tuberculosis drug leads to resistance most rapidly?

Isoniazid. **Explanation:** The development of drug resistance in *Mycobacterium tuberculosis* occurs due to spontaneous genetic mutations. Among the first-line anti-tubercular drugs (ATT), **Isoniazid (INH)** is associated with the most rapid development of resistance when used as monotherapy. **Why Isoniazid is the correct answer:** Resistance to INH occurs primarily due to mutations in the **katG gene**, which encodes the enzyme **catalase-peroxidase**. Since INH is a prodrug, it requires this enzyme for activation. A single-step mutation in katG leads to a high level of resistance. Statistically, the frequency of spontaneous mutations for INH is approximately **1 in 10⁶** bacilli, which is significantly higher than for other drugs like Rifampicin. **Analysis of Incorrect Options:** * **Rifampicin:** Resistance develops due to mutations in the **rpoB gene** (beta-subunit of RNA polymerase). The mutation frequency is much lower (**1 in 10⁸**), making it less likely to develop resistance as rapidly as INH. * **Streptomycin:** Resistance occurs via mutations in the **rpsL or rrs genes** (ribosomal proteins). While resistance can develop, it is generally slower and less frequent than INH in a clinical population. * **Ethambutol:** Resistance develops due to mutations in the **embB gene** (arabinosyl transferase). It is a bacteriostatic drug with a relatively low rate of primary resistance compared to INH. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** INH inhibits **Mycolic acid synthesis**; Rifampicin inhibits **DNA-dependent RNA polymerase**. * **MDR-TB Definition:** Resistance to at least **Isoniazid and Rifampicin**. * **XDR-TB Definition:** MDR-TB plus resistance to any **Fluoroquinolone** and at least one **second-line injectable** (Amikacin, Kanamycin, or Capreomycin). * **Prophylaxis:** INH is the drug of choice for latent TB and chemoprophylaxis in HIV-positive patients or household contacts of open TB cases.

Q: A 30-year-old pregnant woman develops tuberculosis. Which of the following antitubercular drugs should not be used?

Streptomycin. **Explanation:** The correct answer is **Streptomycin** because it is a member of the aminoglycoside class, which is known to be **ototoxic and nephrotoxic**. In pregnancy, Streptomycin crosses the placental barrier and can cause **permanent bilateral congenital deafness** (CN VIII damage) in the fetus. Consequently, it is classified as FDA Pregnancy Category D and is generally contraindicated unless no other alternatives exist. **Analysis of Options:** * **Isoniazid (INH):** Considered safe in pregnancy. However, due to the increased risk of peripheral neuropathy in pregnant women, it must be co-administered with **Pyridoxine (Vitamin B6)**. * **Rifampicin:** Considered safe and is a core component of the RNTCP/WHO regimen for pregnant women. It has no documented teratogenic effects in humans at standard doses. * **Ethambutol:** Considered the safest of the first-line antitubercular drugs during pregnancy; it does not cross the placenta in significant amounts to cause fetal ocular toxicity. **NEET-PG High-Yield Pearls:** 1. **Standard Regimen:** The WHO and National Guidelines recommend the standard 6-month 2HRE/4HR regimen for pregnant women. **Pyrazinamide** is also now considered safe and included in the intensive phase. 2. **Vitamin B6:** Always supplement INH with 10–25 mg/day of Pyridoxine in pregnancy to prevent maternal neuropathy and fetal seizures. 3. **Contraindicated Drugs:** Avoid **Streptomycin** (Ototoxicity), **Ethionamide** (Teratogenic), and **Fluoroquinolones** (Cartilage damage/Arthropathy) during pregnancy. 4. **Breastfeeding:** All first-line ATT drugs are compatible with breastfeeding as they occur in negligible concentrations in breast milk.

Q: Which of the following drugs used for chronic hepatitis B therapy is not administered orally?

Pegylated interferon. The management of Chronic Hepatitis B (CHB) involves two main classes of drugs: **Nucleos(t)ide Analogues (NAs)** and **Immunomodulators**. **1. Why Pegylated Interferon (Peg-IFN) is correct:** Pegylated interferon-alpha (2a or 2b) is a protein-based immunomodulator. Because it is a protein, it would be degraded by gastric enzymes if taken orally. Therefore, it must be administered via **subcutaneous injection** (usually once weekly) [1]. It works by enhancing the host immune response and exerting direct antiviral effects. **2. Why the other options are incorrect:** * **Lamivudine (A):** A nucleoside analogue that inhibits HBV DNA polymerase. It was the first oral agent approved for HBV. * **Adefovir (B):** A nucleotide analogue administered orally. It is now less commonly used due to its lower potency and risk of nephrotoxicity compared to newer agents. * **Telbivudine (C):** An oral L-nucleoside analogue. Like Lamivudine, it has a high rate of resistance, leading to its decreased use in modern clinical practice. **Clinical Pearls for NEET-PG:** * **First-line Oral Agents:** Currently, **Tenofovir (TDF/TAF)** and **Entecavir** are the preferred oral agents due to their high potency and high genetic barrier to resistance. * **Interferon Contraindications:** Peg-IFN should be avoided in patients with decompensated cirrhosis, psychiatric disorders, or autoimmune diseases [1]. * **HBeAg Seroconversion:** Peg-IFN has a higher rate of HBeAg and HBsAg clearance compared to oral NAs but is associated with more side effects (flu-like symptoms, bone marrow suppression) [1]. * **Pregnancy:** Tenofovir is the preferred agent for preventing vertical transmission in highly viremic mothers.

Q: Which of the following drugs is not used in the treatment of multibacillary leprosy as per the recommendations of the World Health Organization?

Minocycline. **Explanation:** The World Health Organization (WHO) recommends a standardized **Multi-Drug Therapy (MDT)** regimen for the treatment of leprosy to prevent the emergence of drug resistance. **Why Minocycline is the correct answer:** While Minocycline possesses significant bactericidal activity against *Mycobacterium leprae*, it is considered a **second-line drug**. It is not part of the standard WHO-recommended MDT for Multibacillary (MB) leprosy. It is primarily used in alternative regimens for patients who cannot tolerate first-line drugs or in the ROM (Rifampicin, Ofloxacin, Minocycline) regimen for Single Lesion Paucibacillary leprosy. **Analysis of incorrect options:** * **A. Rifampicin:** The most potent bactericidal component of the MDT. In MB leprosy, it is administered as a supervised monthly dose of 600 mg. * **B. Clofazimine:** A dye with weak bactericidal and anti-inflammatory properties. It is essential in MB leprosy to prevent the development of Erythema Nodosum Leprosum (ENL) and is given as a 300 mg monthly supervised dose and 50 mg daily self-administered dose. * **C. Dapsone:** A bacteriostatic drug that inhibits folate synthesis. It is a core component of the MDT, administered as a 100 mg daily dose. **High-Yield Clinical Pearls for NEET-PG:** * **WHO MB-MDT Regimen:** Rifampicin (600mg/month), Clofazimine (300mg/month + 50mg/day), and Dapsone (100mg/day) for a total duration of **12 months**. * **Uniform MDT (U-MDT):** Recent WHO guidelines suggest a 6-month regimen of the same three drugs for both PB and MB leprosy to simplify logistics. * **Side Effects:** Clofazimine causes brownish-black skin discoloration; Dapsone can cause hemolysis (especially in G6PD deficiency) and "Dapsone Syndrome."

Q: Which antibiotic can be safely administered to pregnant women?

Cefuroxime. **Explanation:** The safety of drugs during pregnancy is categorized by the FDA. The correct answer is **Cefuroxime**, a second-generation cephalosporin. **1. Why Cefuroxime is correct:** Cephalosporins (along with Penicillins and Erythromycin) are classified as **FDA Category B**. They do not have documented teratogenic effects in humans and are considered the "drugs of choice" for treating bacterial infections during pregnancy. Cefuroxime is safe for treating respiratory tract infections and UTIs in pregnant patients. **2. Why the other options are incorrect:** * **Ciprofloxacin (Option A):** This is a Fluoroquinolone. These are generally avoided in pregnancy because they have a high affinity for bone and cartilage, potentially causing **arthropathy** and permanent cartilage damage in the developing fetus. * **Metronidazole (Option C):** While often used after the first trimester for specific indications, it is traditionally avoided in the **first trimester** due to theoretical concerns regarding mutagenicity (though human data is reassuring, it remains less "safe" than Cephalosporins). * **Chloramphenicol (Option D):** It is contraindicated, especially near term. It can lead to **Gray Baby Syndrome** in neonates because their immature livers cannot conjugate the drug via glucuronidation, leading to toxic accumulation and cardiovascular collapse. **Clinical Pearls for NEET-PG:** * **Safe Antibiotics (CAMP):** **C**ephalosporins, **A**moxicillin/Ampicillin, **M**acrolides (except Estolate form), and **P**enicillins. * **Teratogenic Antibiotics to remember:** * **Tetracyclines:** Discolored teeth and inhibited bone growth. * **Aminoglycosides:** Ototoxicity (CN VIII damage). * **Sulfonamides:** Kernicterus (if given near term). * **Nitrofurantoin:** Hemolysis if the fetus is G6PD deficient.

Q: What is the single dose treatment for chlamydia?

Azithromycin. **Explanation:** The correct answer is **Azithromycin**. **1. Why Azithromycin is correct:** Azithromycin is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit. For uncomplicated genital *Chlamydia trachomatis* infections, a **single oral dose of 1 gram** is highly effective [1]. Its long half-life and excellent tissue penetration allow for a single-dose regimen, which ensures 100% patient compliance—a critical factor in treating sexually transmitted infections (STIs). **2. Why the other options are incorrect:** * **Doxycycline:** While Doxycycline is considered a first-line treatment for Chlamydia (and often preferred in recent CDC guidelines for rectal infections), it is **not a single-dose treatment**. It requires a 100 mg twice-daily regimen for **7 days**. * **Tetracycline:** This is an older generation drug with a shorter half-life and more side effects compared to Doxycycline. It requires multiple daily doses for 7 days and is rarely used now. * **Erythromycin:** This is typically reserved as an alternative for pregnant patients who cannot tolerate Azithromycin. It requires a 7-day course and is associated with significant gastrointestinal upset. **Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) in Pregnancy:** Azithromycin (1g single dose) is the DOC for Chlamydia in pregnant women. * **Syndromic Management (WHO/NACO):** For Urethral Discharge (Grey Kit), the treatment includes **Azithromycin 1g (stat)** plus **Cefixime 400mg (stat)** to cover both Chlamydia and Gonorrhea. * **Lymphogranuloma Venereum (LGV):** Caused by L1, L2, L3 serovars of Chlamydia; the treatment is Doxycycline for **21 days**, not a single dose. * **Partner Management:** Always treat the sexual partner(s) to prevent reinfection ("ping-pong" infection).

Q: Which of the following drugs cannot be used to treat Candida infection?

Griseofulvin. **Explanation:** The correct answer is **Griseofulvin** because of its specific spectrum of activity and mechanism of action. **1. Why Griseofulvin is the correct answer:** Griseofulvin is a fungistatic drug that acts by binding to fungal microtubules, thereby inhibiting mitosis. Its clinical utility is strictly limited to **Dermatophytosis** (infections caused by *Trichophyton, Epidermophyton,* and *Microsporum*). It has **no activity** against *Candida* species or deep systemic mycoses. It is unique because it deposits in keratin precursor cells, making them resistant to fungal invasion. **2. Why the other options are incorrect:** * **Ketoconazole (Option A):** An imidazole derivative that inhibits ergosterol synthesis. It is effective against various *Candida* species, though its systemic use has largely been replaced by safer triazoles (like Fluconazole). * **Nystatin (Option B):** A polyene antibiotic similar to Amphotericin B. It is too toxic for systemic use but is a first-line agent for **topical or oral candidiasis** (thrush). * **Amphotericin B (Option C):** The "gold standard" polyene for systemic fungal infections. It binds to ergosterol in the fungal cell membrane, creating pores. It is highly effective against most *Candida* species, including those causing invasive candidemia. **High-Yield Clinical Pearls for NEET-PG:** * **Griseofulvin** is a potent **Microsomal Enzyme Inducer** (decreases Warfarin efficacy) and can trigger **disulfiram-like reactions**. * **Drug of Choice (DOC) for Candidiasis:** Fluconazole is the DOC for most localized infections; Echinocandins (e.g., Caspofungin) are often preferred for systemic candidemia in unstable patients. * **Griseofulvin** absorption is significantly increased when taken with a **fatty meal**.

Q: Which of the following drugs is not used in the treatment of Mycobacterium avium intracellular infection?

Eflornithine. **Explanation:** The treatment of *Mycobacterium avium-intracellulare* complex (MAC) requires a multidrug regimen due to its high level of intrinsic resistance to standard antitubercular drugs. **Why Eflornithine is the correct answer:** **Eflornithine** is an antiprotozoal medication, not an antimycobacterial agent. It acts as an irreversible inhibitor of ornithine decarboxylase. Its primary clinical uses include the treatment of **African Trypanosomiasis** (Sleeping Sickness caused by *Trypanosoma brucei gambiense*) and topically to reduce unwanted facial hair (hirsutism) in women. It has no activity against MAC. **Analysis of Incorrect Options:** * **Clarithromycin (Option A):** Macrolides (Clarithromycin or Azithromycin) are the **backbone** of MAC therapy. They are used for both prophylaxis (in HIV patients with CD4 <50 cells/mm³) and active treatment. * **Ethambutol (Option C):** This is a standard component of the multidrug regimen for MAC. It is added to a macrolide to enhance efficacy and prevent the emergence of drug resistance. * **Rifabutin (Option D):** Rifabutin is preferred over Rifampin for MAC because it is more potent against the complex and has fewer drug-drug interactions with antiretroviral therapy (ART) in HIV patients. **High-Yield Clinical Pearls for NEET-PG:** * **Standard MAC Regimen:** Clarithromycin + Ethambutol + Rifabutin. * **Prophylaxis:** Indicated in HIV patients when CD4 count falls below **50 cells/mm³**. * **Eflornithine Mnemonic:** "Resurrection drug" for African Sleeping Sickness (coma stage). * **Rifabutin Side Effect:** Watch for **uveitis** and orange discoloration of secretions.

Q: Which of the following antimalarial drugs possesses immunomodulatory effects?

Hydroxychloroquine. **Explanation:** The correct answer is **Hydroxychloroquine (HCQ)**. While both Chloroquine and Hydroxychloroquine are 4-aminoquinolines, HCQ is specifically recognized for its potent **immunomodulatory properties** in addition to its antimalarial action. **Why Hydroxychloroquine is correct:** HCQ acts as a weak base that accumulates in intracellular lysosomes, increasing the pH. This interferes with antigen processing and inhibits the stimulation of **Toll-like receptors (TLRs)**, specifically TLR-7 and TLR-9. This leads to a decrease in the production of pro-inflammatory cytokines like Type 1 Interferons, TNF-α, and IL-6. Due to this mechanism, HCQ is a first-line **Disease-Modifying Anti-Rheumatic Drug (DMARD)** used in systemic lupus erythematosus (SLE) and rheumatoid arthritis. **Why other options are incorrect:** * **Chloroquine:** Although it has some anti-inflammatory properties, it is significantly more toxic (especially ocular toxicity) than HCQ. In modern clinical practice, the term "immunomodulator" in this class almost exclusively refers to HCQ due to its superior safety profile for long-term autoimmune therapy. * **Quinine:** This is a cinchona alkaloid used primarily for severe malaria or chloroquine-resistant cases. It lacks significant immunomodulatory effects and is known for its narrow therapeutic index (Cinchonism). **High-Yield NEET-PG Pearls:** * **Ocular Toxicity:** Both drugs cause "Bull’s eye maculopathy," but the risk is significantly lower with HCQ (safe dose <5mg/kg/day). * **Drug of Choice:** HCQ is the DOC for maintaining remission in **SLE** and is safe during pregnancy for SLE patients. * **Side Effects:** Watch for QTc prolongation and hemolysis in G6PD-deficient patients.

Question 1

Which of the following antimicrobials needs dose reduction even in mild renal failure?

Accepted Answer

Ethambutol

Answer

Ciprofloxacin

Answer

Carbenicillin

Answer

Cefotaxime

Question 2

Which anti-tuberculosis drug leads to resistance most rapidly?

Accepted Answer

Isoniazid

Answer

Streptomycin

Answer

Rifampicin

Answer

Ethambutol

Question 3

A 30-year-old pregnant woman develops tuberculosis. Which of the following antitubercular drugs should not be used?

Accepted Answer

Streptomycin

Answer

Isoniazid (INH)

Answer

Rifampicin

Answer

Ethambutol

Question 4

Which of the following drugs used for chronic hepatitis B therapy is not administered orally?

Accepted Answer

Pegylated interferon

Answer

Lamivudine

Answer

Adefovir

Answer

Telbivudine

Question 5

Which of the following drugs is not used in the treatment of multibacillary leprosy as per the recommendations of the World Health Organization?

Accepted Answer

Minocycline

Answer

Rifampicin

Answer

Clofazimine

Answer

Dapsone

Question 6

Which antibiotic can be safely administered to pregnant women?

Accepted Answer

Cefuroxime

Answer

Ciprofloxacin

Answer

Metronidazole

Answer

Chloramphenicol

Question 7

What is the single dose treatment for chlamydia?

Accepted Answer

Azithromycin

Answer

Doxycycline

Answer

Tetracycline

Answer

Erythromycin

Question 8

Which of the following drugs cannot be used to treat Candida infection?

Accepted Answer

Griseofulvin

Answer

Ketoconazole

Answer

Nystatin

Answer

Amphotericin

Question 9

Which of the following drugs is not used in the treatment of Mycobacterium avium intracellular infection?

Accepted Answer

Eflornithine

Answer

Clarithromycin

Answer

Ethambutol

Answer

Rifabutin

Question 10

Which of the following antimalarial drugs possesses immunomodulatory effects?

Accepted Answer

Hydroxychloroquine

Answer

Chloroquine

Answer

Quinine

Answer

All of the above

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?